| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | +63% | $30,582,610 | +$11,592,390 | 6,318,721 | +61% | FMR LLC | 31 Jan 2025 |
| ACORN BIOVENTURES, L.P. | 5.2% | $14,115,428 | 2,580,517 | Anders Hove | 25 Jun 2025 | |||
| BAKER BROS. ADVISORS LP | 5% | -26% | $11,882,723 | -$2,550,075 | 2,455,108 | -18% | Baker Bros. Advisors LP | 31 Mar 2025 |
As of 30 Sep 2025, 80 institutional investors reported holding 22,652,478 shares of Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL). This represents 46% of the company’s total 49,625,327 outstanding shares.
The largest institutional shareholders of Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) together control 44% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 17% | 8,233,385 | -0% | 0% | $41,990,263 |
| ACORN CAPITAL ADVISORS, LLC | 5.2% | 2,580,517 | 0% | 6.7% | $13,160,637 |
| BlackRock, Inc. | 4.8% | 2,379,330 | +3.4% | 0% | $12,134,582 |
| VANGUARD GROUP INC | 4% | 2,007,112 | +12% | 0% | $10,236,272 |
| Portolan Capital Management, LLC | 2.8% | 1,384,142 | -15% | 0.38% | $7,059,124 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 928,197 | +2.7% | 0% | $4,734,652 |
| Halter Ferguson Financial Inc. | 1.4% | 698,004 | -10% | 0.86% | $3,559,821 |
| STATE STREET CORP | 1.4% | 688,766 | +5.6% | 0% | $3,512,707 |
| Sands Capital Alternatives, LLC | 0.82% | 405,837 | 0% | 0.45% | $2,069,769 |
| NORTHERN TRUST CORP | 0.62% | 306,775 | +6.6% | 0% | $1,564,553 |
| CITADEL ADVISORS LLC | 0.51% | 252,291 | 0% | $1,286,684 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.45% | 223,821 | -37% | 0% | $1,141,487 |
| Nuveen, LLC | 0.42% | 209,662 | +127% | 0% | $1,069,276 |
| Tanager Wealth Management LLP | 0.4% | 198,175 | +0.79% | 0.11% | $1,010,693 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.28% | 137,888 | +60% | 0% | $703,229 |
| MILLENNIUM MANAGEMENT LLC | 0.28% | 136,670 | 0% | $697,017 | |
| TWO SIGMA INVESTMENTS, LP | 0.27% | 136,116 | -63% | 0% | $694,192 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.24% | 121,004 | +6.4% | 0% | $617,120 |
| MARSHALL WACE, LLP | 0.21% | 103,847 | -36% | 0% | $529,621 |
| Bank of New York Mellon Corp | 0.19% | 94,569 | +8.9% | 0% | $482,300 |
| UBS Group AG | 0.19% | 94,071 | +14% | 0% | $479,762 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.17% | 82,221 | +0.76% | 0% | $419,000 |
| Kovitz Investment Group Partners, LLC | 0.16% | 79,316 | 0% | $404,512 | |
| MORGAN STANLEY | 0.15% | 75,941 | -33% | 0% | $387,300 |
| ALLIANCEBERNSTEIN L.P. | 0.14% | 69,110 | 0% | 0% | $352,461 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 295 | $1,667 | +$542 | $5.65 | 1 |
| 2025 Q3 | 22,652,478 | $115,539,883 | -$1,871,335 | $5.10 | 80 |
| 2025 Q2 | 23,037,394 | $116,569,933 | +$8,831,720 | $5.06 | 78 |
| 2025 Q1 | 21,190,126 | $119,726,836 | +$12,537,033 | $5.65 | 82 |
| 2024 Q4 | 17,950,985 | $155,743,026 | +$97,379,454 | $8.68 | 70 |
| 2024 Q3 | 6,693,196 | $46,384,699 | +$3,074,083 | $6.93 | 51 |
| 2024 Q2 | 5,961,761 | $36,964,279 | +$13,959,987 | $6.20 | 45 |
| 2024 Q1 | 3,780,257 | $5,972,529 | -$231,572 | $1.58 | 18 |
| 2023 Q4 | 4,027,160 | $5,919,504 | -$1,196,574 | $1.47 | 21 |
| 2023 Q3 | 5,257,852 | $4,856,205 | -$147,500 | $0.92 | 19 |
| 2023 Q2 | 5,370,044 | $6,766,125 | -$142,743 | $1.26 | 19 |
| 2023 Q1 | 5,478,268 | $7,437,200 | +$69,459 | $1.35 | 20 |
| 2022 Q4 | 5,420,630 | $9,702,154 | -$1,788,500 | $1.79 | 20 |
| 2022 Q3 | 6,080,809 | $19,096,287 | -$834,398 | $3.14 | 22 |
| 2022 Q2 | 6,345,954 | $20,561,000 | -$1,159,878 | $3.24 | 21 |
| 2022 Q1 | 6,674,026 | $33,969,000 | -$1,719,786 | $5.08 | 21 |
| 2021 Q4 | 6,951,728 | $54,359,000 | +$875,765 | $7.82 | 20 |
| 2021 Q3 | 4,884,284 | $52,945,000 | +$44,146,000 | $10.84 | 12 |